The physician argues GLP-1 drugs are changing how chronic disease is viewed and urges people to act before illness shows up. A brief opinion post.
Recap by typeshit. Post by Raj Panjabi M.D. on X.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
KontraInvest puts Wegovy HD's annual run rate near $0.5bn, with volume at about 40% of Foundayo's.
An educational social post from Dr. Levine sorting which diabetes medications he rates best and which he flags as concerns.
Loading…